Scarica l'app Stockscreener
1.10
11.29%
-0.14
Dopo l'orario di chiusura:
1.10
Precedente Chiudi:
$1.24
Aprire:
$1.16
Volume 24 ore:
3.95M
Relative Volume:
2.20
Capitalizzazione di mercato:
$178.68M
Reddito:
$400.57M
Utile/perdita netta:
$9.21M
Rapporto P/E:
27.50
EPS:
0.04
Flusso di cassa netto:
$146.36M
1 W Prestazione:
-16.67%
1M Prestazione:
+46.57%
6M Prestazione:
-26.17%
1 anno Prestazione:
-77.82%
Intervallo 1D:
$1.01
$1.18
Intervallo di 1 settimana:
$1.01
$1.3488
Portata 52W:
$0.5271
$5.1288
Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
Nome
Ironwood Pharmaceuticals Inc
Settore
Telefono
617-621-7722
Indirizzo
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Confronta IRWD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
1.10 | 212.79M | 400.57M | 9.21M | 146.36M | 0.04 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-15 | Downgrade | Jefferies | Buy → Hold |
| 2025-04-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-04-14 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-09-09 | Iniziato | Leerink Partners | Market Perform |
| 2024-08-08 | Downgrade | CapitalOne | Overweight → Equal Weight |
| 2024-01-17 | Iniziato | Craig Hallum | Buy |
| 2023-12-14 | Iniziato | Wells Fargo | Overweight |
| 2023-11-09 | Iniziato | Jefferies | Buy |
| 2023-09-28 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-09-02 | Iniziato | CapitalOne | Overweight |
| 2022-04-22 | Iniziato | Piper Sandler | Overweight |
| 2020-09-30 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-06-17 | Iniziato | Northland Capital | Outperform |
| 2019-07-10 | Ripresa | Credit Suisse | Neutral |
| 2019-03-27 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2019-02-25 | Aggiornamento | H.C. Wainwright | Sell → Neutral |
| 2019-01-24 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2018-11-07 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2018-11-07 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-07-23 | Iniziato | H.C. Wainwright | Sell |
| 2018-05-09 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-01-05 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2017-12-06 | Downgrade | Mizuho | Buy → Neutral |
| 2017-07-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2017-05-03 | Iniziato | Wells Fargo | Outperform |
| 2017-04-07 | Reiterato | Mizuho | Buy |
| 2017-02-22 | Reiterato | Barclays | Equal Weight |
| 2016-11-04 | Reiterato | Mizuho | Buy |
| 2016-10-24 | Reiterato | Wedbush | Neutral |
| 2016-10-10 | Reiterato | Mizuho | Buy |
| 2016-09-27 | Reiterato | WallachBeth | Hold |
Mostra tutto
Ironwood Pharmaceuticals Inc Borsa (IRWD) Ultime notizie
Is Ironwood Pharmaceuticals Inc.’s growth already priced inWeekly Stock Report & Safe Entry Momentum Tips - khodrobank.com
Ironwood Pharma Regains Nasdaq Compliance - TipRanks
Ironwood Pharmaceuticals Inc. stock trendline breakdownQuarterly Profit Report & Long-Term Investment Growth Plans - Newser
Published on: 2025-09-03 06:20:24 - Newser
Published on: 2025-09-03 04:31:42 - Newser
Combining price and volume data for Ironwood Pharmaceuticals Inc.CEO Change & Short-Term Trading Opportunity Alerts - Newser
Is Ironwood Pharmaceuticals Inc. reversing from oversold territoryJuly 2025 Sentiment & Long-Term Safe Investment Plans - Newser
When is the best time to exit Ironwood Pharmaceuticals Inc.Portfolio Update Report & Low Drawdown Investment Strategies - Newser
Using Ichimoku Cloud for Ironwood Pharmaceuticals Inc. technicalsQuarterly Trade Summary & High Win Rate Trade Tips - Newser
Ironwood Pharmaceuticals Inc. stock chart pattern explainedEarnings Summary Report & Risk Managed Investment Signals - Newser
Is Ironwood Pharmaceuticals Inc. stock entering bullish territoryMarket Sentiment Review & Weekly Hot Stock Watchlists - Newser
Will Ironwood Pharmaceuticals Inc. stock recover after recent drop2025 Winners & Losers & Risk Managed Investment Strategies - Newser
Will Ironwood Pharmaceuticals Inc. benefit from rate cuts2025 Buyback Activity & Safe Entry Zone Tips - khodrobank.com
Comparing Ironwood Pharmaceuticals Inc. in custom built stock radars2025 AllTime Highs & Free Reliable Trade Execution Plans - Newser
Is Ironwood Pharmaceuticals Inc. likely to announce a buyback2025 Risk Factors & Low Drawdown Investment Ideas - خودرو بانک
Published on: 2025-09-02 07:32:33 - khodrobank.com
Should you hold or exit Ironwood Pharmaceuticals Inc. nowJuly 2025 Price Swings & Free Expert Approved Momentum Trade Ideas - Newser
Using data models to predict Ironwood Pharmaceuticals Inc. stock movementWeekly Profit Analysis & Technical Confirmation Alerts - Newser
What indicators show strength in Ironwood Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Safe Entry Zone Tips - Newser
What Fibonacci levels say about Ironwood Pharmaceuticals Inc. reboundExit Point & AI Driven Price Predictions - Newser
Published on: 2025-08-31 13:49:26 - beatles.ru
How hedge fund analytics apply to Ironwood Pharmaceuticals Inc. stockGold Moves & Safe Capital Investment Plans - Newser
RSI Reset May Fuel Rebound in Ironwood Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Risk adjusted return profile for Ironwood Pharmaceuticals Inc. analyzedPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser
Options Data Show Bullish Bias in Ironwood Pharmaceuticals Inc.July 2025 Rallies & Safe Entry Trade Reports - beatles.ru
Analysts Spot Bullish Divergence in Ironwood Pharmaceuticals Inc.2025 Stock Rankings & Safe Capital Preservation Plans - beatles.ru
Analyzing drawdowns of Ironwood Pharmaceuticals Inc. with statistical toolsInsider Buying & Low Risk Entry Point Guides - Newser
Published on: 2025-08-29 17:20:59 - Newser
What are Ironwood Pharmaceuticals Inc.’s recent SEC filings showingDividend Hike & Free Technical Confirmation Trade Alerts - sundaytimes.kr
What earnings revisions data tells us about Ironwood Pharmaceuticals Inc.Trend Reversal & Free Safe Capital Growth Stock Tips - Newser
Measuring Ironwood Pharmaceuticals Inc.’s beta against major indices2025 Bull vs Bear & Reliable Price Breakout Signals - Newser
Ironwood Pharmaceuticals Inc Azioni (IRWD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ironwood Pharmaceuticals Inc Azioni (IRWD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| John Minardo | Chief Legal Officer |
Aug 11 '25 |
Sale |
0.84 |
7,754 |
6,513 |
400,378 |
| Martini Gregory S. | Chief Financial Officer |
Aug 11 '25 |
Sale |
0.84 |
1,265 |
1,063 |
182,545 |
| Silver Ronald | Principal Accounting Officer |
Aug 11 '25 |
Sale |
0.84 |
2,846 |
2,391 |
276,809 |
3.60%
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):